Several therapies have been proposed in PPCM in addition to conventional treatment for heart failure, including apheresis, intravenous gamma-globulin, immunomodulators, anti-viral agents, and particularly prolactin release inhibitors such as bromocriptine [18]. This evidence concerns the gene PRL and heart failure.